Clinical Trial Update: Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells [NA]

View source ↗

Summary

Clinical trial update on follow-up of patients with thoracic or abdominal aortic aneurysm receiving different doses of Circulant Endothelial Progenitor Cells.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm
• Thoracic Aortic Aneurysm

Drugs mentioned

• Circulant Endothelial Progenitor Cells

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Thoracic or Abdominal Aortic Aneurysm With no Indication for Surgical Treatment | NA | Status: UNKNOWN